Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Fase 3-evaluering af effektivitet og sikkerhed for AR882 hos gigtpatienter (AR882-301)

24. september 2026 opdateret af: Arthrosi Therapeutics

En fase 3 randomiseret, dobbeltblind, multicenter, placebo-kontrolleret undersøgelse for at evaluere effektiviteten og sikkerheden for AR882 hos deltagere med gigt

This study will assess the serum uric acid lowering effect and safety of AR882 in gout patients at two doses compared to placebo over 12 months

Studieoversigt

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

866

Fase

  • Fase 3

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forenede Stater, 35215
        • Arthrosi Investigative Site (620)
      • Huntsville, Alabama, Forenede Stater, 35801
        • Arthrosi Investigative Site (616)
    • Arizona
      • Peoria, Arizona, Forenede Stater, 85381
        • Arthrosi Investigative Site (680)
      • Phoenix, Arizona, Forenede Stater, 85018
        • Arthrosi Investigative Site (640)
    • Arkansas
      • Little Rock, Arkansas, Forenede Stater, 72205
        • Arthrosi Investigative Site (617)
    • California
      • Garden Grove, California, Forenede Stater, 92844
        • Arthrosi Investigative Site (614)
      • La Mesa, California, Forenede Stater, 91942
        • Arthrosi Investigative Site (618)
      • La Mesa, California, Forenede Stater, 91942
        • Arthrosi Investigative Site (687)
      • La Palma, California, Forenede Stater, 90623
        • Arthrosi Investigative Site (655)
      • Lincoln, California, Forenede Stater, 95648
        • Arthrosi Investigative Site (632)
      • Lomita, California, Forenede Stater, 90717
        • Arthrosi Investigative Site (605)
      • Long Beach, California, Forenede Stater, 90806
        • Arthrosi Investigative Site (675)
      • Santa Monica, California, Forenede Stater, 90404
        • Arthrosi Investigative Site (603)
      • Tarzana, California, Forenede Stater, 91356
        • Arthrosi Investigative Site (672)
      • Thousand Oaks, California, Forenede Stater, 91360
        • Arthrosi Investigative Site (656)
    • Colorado
      • Aurora, Colorado, Forenede Stater, 80012
        • Arthrosi Investigative Site (660)
      • Colorado Springs, Colorado, Forenede Stater, 80909
        • Arthrosi Investigative Site (669)
      • Fort Collins, Colorado, Forenede Stater, 80528
        • Arthrosi Investigative Site (612)
    • Florida
      • Cooper City, Florida, Forenede Stater, 33024
        • Arthrosi Investigative Site (665)
      • Jupiter, Florida, Forenede Stater, 33458
        • Arthrosi Investigative Site (613)
      • Miami, Florida, Forenede Stater, 33173
        • Arthrosi Investigative Site (611)
      • Miami, Florida, Forenede Stater, 33176
        • Arthrosi Investigative Site (644)
      • Palmetto Bay, Florida, Forenede Stater, 33157
        • Arthrosi Investigative Site (694)
      • Sanford, Florida, Forenede Stater, 32771
        • Arthrosi Investigative Site (615)
      • Tampa, Florida, Forenede Stater, 33609
        • Arthrosi Investigative Site (600)
    • Georgia
      • Atlanta, Georgia, Forenede Stater, 30329
        • Arthrosi Investigative Site (673)
      • Marietta, Georgia, Forenede Stater, 30060
        • Arthrosi Investigative Site (652)
    • Hawaii
      • Honolulu, Hawaii, Forenede Stater, 96814
        • Arthrosi Investigative Site (658)
    • Idaho
      • Boise, Idaho, Forenede Stater, 83713
        • Arthrosi Investigative Site (676)
      • Meridian, Idaho, Forenede Stater, 83642
        • Arthrosi Investigative Site (634)
    • Illinois
      • Chicago, Illinois, Forenede Stater, 60602
        • Arthrosi Investigative Site (657)
      • Melrose Park, Illinois, Forenede Stater, 60160
        • Arthrosi Investigative Site (648)
    • Indiana
      • Indianapolis, Indiana, Forenede Stater, 46202
        • Arthrosi Investigative Site (678)
    • Kansas
      • Overland Park, Kansas, Forenede Stater, 66209
        • Arthrosi Investigative Site (679)
    • Kentucky
      • Louisville, Kentucky, Forenede Stater, 40205
        • Arthrosi Investigative Site (674)
    • Louisiana
      • Mandeville, Louisiana, Forenede Stater, 70471
        • Arthrosi Investigative Site (627)
      • New Orleans, Louisiana, Forenede Stater, 70115
        • Arthrosi Investigative Site (650)
      • Prairieville, Louisiana, Forenede Stater, 70769
        • Arthrosi Investigative Site (641)
    • Maryland
      • Oxon Hill, Maryland, Forenede Stater, 20745
        • Arthrosi Investigative Site (662)
      • Rockville, Maryland, Forenede Stater, 20852
        • Arthrosi Investigative Site (653)
    • Massachusetts
      • Fall River, Massachusetts, Forenede Stater, 02721
        • Arthrosi Investigative Site (636)
    • Michigan
      • Farmington Hills, Michigan, Forenede Stater, 48334
        • Arthrosi Investigative Site (628)
      • Southfield, Michigan, Forenede Stater, 48076
        • Arthrosi Investigative Site (645)
    • Mississippi
      • Gulfport, Mississippi, Forenede Stater, 39503
        • Arthrosi Investigative Site (633)
      • Jackson, Mississippi, Forenede Stater, 39202
        • Arthrosi Investigative Site (635)
      • Olive Branch, Mississippi, Forenede Stater, 38654
        • Arthrosi Investigative Site (693)
    • Missouri
      • Springfield, Missouri, Forenede Stater, 65807
        • Arthrosi Investigative Site (637)
      • Town and Country, Missouri, Forenede Stater, 63017
        • Arthrosi Investigative Site (626)
    • Montana
      • Missoula, Montana, Forenede Stater, 59808
        • Arthrosi Investigative Site (664)
    • Nebraska
      • Lincoln, Nebraska, Forenede Stater, 68516
        • Arthrosi Investigative Site (610)
      • Omaha, Nebraska, Forenede Stater, 68114
        • Arthrosi Investigative Site (684)
      • Omaha, Nebraska, Forenede Stater, 68144
        • Arthrosi Investigative Site (651)
    • Nevada
      • Las Vegas, Nevada, Forenede Stater, 89102
        • Arthrosi Investigative Site (686)
    • New York
      • Brooklyn, New York, Forenede Stater, 11215
        • Arthrosi Investigative Site (661)
      • Hartsdale, New York, Forenede Stater, 10530
        • Arthrosi Investigative Site (663)
    • North Carolina
      • Charlotte, North Carolina, Forenede Stater, 28207
        • Arthrosi Investigative Site (625)
      • Charlotte, North Carolina, Forenede Stater, 28277
        • Arthrosi Investigative Site (681)
      • Raleigh, North Carolina, Forenede Stater, 27607
        • Arthrosi Investigative Site (683)
      • Shelby, North Carolina, Forenede Stater, 28150
        • Arthrosi Investigative Site (649)
    • North Dakota
      • Fargo, North Dakota, Forenede Stater, 58104
        • Arthrosi Investigative Site (666)
    • Ohio
      • Mason, Ohio, Forenede Stater, 45040
        • Arthrosi Investigative Site (671)
    • Oklahoma
      • Norman, Oklahoma, Forenede Stater, 73072
        • Arthrosi Investigative Site (631)
      • Tulsa, Oklahoma, Forenede Stater, 74133
        • Arthrosi Investigative Site (642)
    • Pennsylvania
      • Horsham, Pennsylvania, Forenede Stater, 19044
        • Arthrosi Investigative Site (647)
      • Philadelphia, Pennsylvania, Forenede Stater, 19107
        • Arthrosi Investigative Site (623)
    • South Carolina
      • Charleston, South Carolina, Forenede Stater, 29407
        • Arthrosi Investigative Site (638)
      • Fort Mill, South Carolina, Forenede Stater, 29707
        • Arthrosi Investigative Site (604)
      • North Charleston, South Carolina, Forenede Stater, 29405
        • Arthrosi Investigative Site (608)
    • Tennessee
      • Chattanooga, Tennessee, Forenede Stater, 37404
        • Arthrosi Investigative Site (619)
      • Hendersonville, Tennessee, Forenede Stater, 37075
        • Arthrosi Investigative Site (624)
    • Texas
      • Amarillo, Texas, Forenede Stater, 79106
        • Arthrosi Investigative Site (670)
      • Austin, Texas, Forenede Stater, 78735
        • Arthrosi Investigative Site (677)
      • DeSoto, Texas, Forenede Stater, 75115
        • Arthrosi Investigative Site (639)
      • Houston, Texas, Forenede Stater, 77074
        • Arthrosi Investigative Site (601)
      • Plano, Texas, Forenede Stater, 75024
        • Arthrosi Investigative Site (688)
      • Prosper, Texas, Forenede Stater, 75078
        • Arthrosi Investigative Site (689)
      • Tomball, Texas, Forenede Stater, 77375
        • Arthrosi Investigative Site (646)
      • Tomball, Texas, Forenede Stater, 77375
        • Arthrosi Investigative Site (659)
    • Utah
      • Clinton, Utah, Forenede Stater, 84015
        • Arthrosi Investigative Site (643)
      • Salt Lake City, Utah, Forenede Stater, 84121
        • Arthrosi Investigative Site (609)
      • Salt Lake City, Utah, Forenede Stater, 84124
        • Arthrosi Investigative Site (654)
    • Washington
      • Bellevue, Washington, Forenede Stater, 98004
        • Arthrosi Investigative Site (685)
    • Wisconsin
      • Kenosha, Wisconsin, Forenede Stater, 53144
        • Arthrosi Investigative Site (668)

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 85 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • History of gout
  • Occurrence of ≥ 2 self-reported gout flares in the last 12 months
  • Body weight no less than 50 kg
  • Patients who are NOT on approved urate-lowering therapy (ULT) must have sUA ≥ 7 mg/dL
  • Patients who are on medically appropriate ULT must have sUA > 6 mg/dL
  • Serum creatinine must be < 3.0 mg/dL and estimated CLcr ≥ 30 mL/min

Exclusion Criteria:

  • Malignancy within 5 years, except for successfully treated basal or squamous cell carcinoma of the skin
  • Pregnant or breastfeeding
  • History of symptomatic kidney stones within the past 6 months

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Firedobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: AR882 50 mg

AR882 50 mg taken once daily for 12 months

Solid Oral Capsule

Eksperimentel: AR882 75 mg

AR882 75 mg taken once daily for 12 months

Solid Oral Capsule

Placebo komparator: Placebo

AR882 matching placebo taken once daily for 12 months

Matching Solid Oral Capsule Placebo

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Serum urate (uric acid) (sUA) level < 6 mg/dL at month 6
Tidsramme: 24 weeks

Comparison of the treatment groups for the proportion of patients with serum urate (uric acid) (sUA) level < 6 mg/dL at month 6

24 weeks

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in tophus burden by month 12
Tidsramme: 48 weeks

Comparison of the treatment groups for the proportion of patients who experience a complete response, marked or partial response, of at least 1 target tophus at Month 12, with no evidence of disease progression (no new tophus or single tophus showing progression) and patients with no new tophi formation at month 12 as determined using the computer-assisted photographic evaluation in rheumatology (CAPER) method

48 weeks
Serum urate (uric acid) (sUA) level < 6 mg/dL from the end of month 9 to the end of month 12
Tidsramme: 12 weeks

Comparison of the treatment groups for the proportion of patients with serum urate (uric acid) (sUA) level < 6 mg/dL for the 3-month period from the end of month 9 to the end of month 12

12 weeks
Change in tophus burden by month 6
Tidsramme: 24 weeks

Comparison of the treatment groups for the proportion of patients who experience a complete response, marked or partial response, of at least 1 target tophus at Month 6, with no evidence of disease progression (no new tophus or single tophus showing progression) and patients with no new tophi formation at month 6 as determined using the computer-assisted photographic evaluation in rheumatology (CAPER) method

24 weeks
Incidence of Adverse Events
Tidsramme: 56 weeks

Treatment Emergent Adverse Events and Serious Adverse Event incidence

56 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Studieleder: Robert Keenan, MD, Arthrosi Therapeutics, Inc.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

11. marts 2025

Primær færdiggørelse (Faktiske)

31. august 2026

Studieafslutning (Faktiske)

18. september 2026

Datoer for studieregistrering

Først indsendt

21. februar 2025

Først indsendt, der opfyldte QC-kriterier

21. februar 2025

Først opslået (Faktiske)

26. februar 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

28. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

24. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ja

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner